<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Clinical Trial Matching Report - Visual</title>

    <!-- Chart.js for charts -->
    <script src="https://cdnjs.cloudflare.com/ajax/libs/Chart.js/3.9.1/chart.min.js"></script>

    <!-- Leaflet.js for interactive maps -->
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/leaflet/1.9.4/leaflet.css" />
    <script src="https://cdnjs.cloudflare.com/ajax/libs/leaflet/1.9.4/leaflet.min.js"></script>

    
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            line-height: 1.5;
            color: #333;
            background-color: #f8f9ff;
        }

        .container {
            max-width: 1600px;
            margin: 0 auto;
            padding: 20px;
        }

        .header {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 25px;
            border-radius: 12px;
            margin-bottom: 25px;
            text-align: center;
        }

        .header h1 {
            font-size: 2.2em;
            margin-bottom: 8px;
        }

        /* FIXED: Better 3-column layout with consistent heights */
        .visual-summary {
            display: grid;
            grid-template-columns: 380px 1fr 2fr;
            gap: 20px;
            margin-bottom: 35px;
            height: 450px; /* Fixed height for alignment */
        }

        .chart-container {
            background: #fff;
            padding: 20px;
            border-radius: 12px;
            box-shadow: 0 4px 6px rgba(0,0,0,0.1);
            display: flex;
            flex-direction: column;
            min-height: 450px; /* FIXED: Minimum height */
        }

        .chart-container h3 {
            text-align: center;
            margin-bottom: 15px;
            color: #2c3e50;
            font-size: 1.1em;
        }

        /* FIXED: Medical Profile Card - Compact */
        .medical-profile-card {
            background: #fff;
            padding: 20px;
            border-radius: 12px;
            box-shadow: 0 4px 6px rgba(0,0,0,0.1);
            display: flex;
            flex-direction: column;
            min-height: 450px; /* FIXED: Minimum height to match other columns */
        }

        .profile-header {
            font-weight: bold;
            font-size: 1.1em;
            color: #2c3e50;
            margin-bottom: 15px;
            padding-bottom: 8px;
            border-bottom: 2px solid #e9ecef;
            text-align: center;
        }

        .profile-section {
            margin-bottom: 16px;
            flex: 1;
        }

        .profile-section h4 {
            color: #495057;
            font-size: 0.85em;
            margin-bottom: 8px;
            border-bottom: 1px solid #e9ecef;
            padding-bottom: 3px;
        }
        
        .profile-section:last-child {
            margin-bottom: auto;
        }

        .profile-item {
            display: flex;
            justify-content: space-between;
            margin-bottom: 5px;
            font-size: 0.8em;
        }

        .profile-label {
            color: #6c757d;
        }

        .profile-value {
            color: #212529;
            font-weight: 500;
            text-align: right;
        }

        /* FIXED: Compact Spotlight Section */
        .spotlight-section {
            position: relative;
            flex: 1;
            display: flex;
            flex-direction: column;
        }

        .spotlight-container {
            display: flex;
            flex-direction: column;
            height: 100%;
            gap: 8px;
            justify-content: space-between; /* ADDED: Distribute content evenly */
            min-height: 420px;
        }


        /* FIXED: Smaller spotlight feature */
         .spotlight-feature {
            background: linear-gradient(135deg, #28a745, #20c997);
            color: white;
            padding: 18px 25px; /* REDUCED padding */
            border-radius: 12px;
            text-align: center;
            box-shadow: 0 6px 12px rgba(40, 167, 69, 0.3);
            position: relative;
            overflow: hidden;
            transition: transform 0.3s ease;
            flex-shrink: 0;
        }
        
        .spotlight-number {
            font-size: 2.8em; /* REDUCED from 3.2em */
            font-weight: bold;
            margin-bottom: 4px;
            animation: countUp 1s ease-out;
        }
        
        .spotlight-label {
            font-size: 1em; /* REDUCED from 1.1em */
            font-weight: 600;
            margin-bottom: 2px;
        }
        
        .spotlight-subtitle {
            font-size: 0.85em; /* REDUCED from 0.9em */
            opacity: 0.9;
        }

        /* FIXED: Better stats boxes layout */
        .stats-boxes-row {
            display: grid;
            grid-template-columns: 1fr 1fr 1fr;
            gap: 8px;
            margin-bottom: 8px;
            flex-shrink: 0;
        }
        
        .stat-box {
            background: linear-gradient(135deg, #f8f9fa, #e9ecef);
            border: 1px solid #dee2e6;
            border-radius: 8px;
            padding: 10px 6px; /* REDUCED padding */
            text-align: center;
            box-shadow: 0 2px 4px rgba(0,0,0,0.05);
            transition: all 0.3s ease;
        }
        
        .stat-number {
            font-size: 1.3em; /* REDUCED from 1.4em */
            font-weight: bold;
            color: #2c3e50;
            margin-bottom: 3px;
            line-height: 1;
        }
        
        .stat-label {
            font-size: 0.75em; /* REDUCED from 0.8em */
            font-weight: 600;
            color: #495057;
            margin-bottom: 2px;
            line-height: 1;
        }
        
        .stat-subtitle {
            font-size: 0.7em;
            color: #6c757d;
            line-height: 1;
        }

        .other-matches-chart {
            flex: 1;
            position: relative;
            min-height: 180px;
            padding: 8px 12px 30px 8px; /* ADDED: padding bottom and right for axis labels */
            margin-bottom: 10px; /* ADDED: extra margin at bottom */
            margin-top: 0;
        }

        @keyframes countUp {
            from {
                transform: scale(0.5);
                opacity: 0;
            }
            to {
                transform: scale(1);
                opacity: 1;
            }
        }

        /* Map Section Styles */
        .map-card {
            background: #fff;
            padding: 20px;
            border-radius: 12px;
            box-shadow: 0 4px 6px rgba(0,0,0,0.1);
            display: flex;
            flex-direction: column;
            min-height: 450px; /* FIXED: Minimum height */
        }

        .map-header {
            font-weight: bold;
            font-size: 1.1em;
            color: #2c3e50;
            margin-bottom: 15px;
            display: flex;
            justify-content: space-between;
            align-items: center;
        }

        .map-container {
            flex: 1;
            border-radius: 8px;
            position: relative;
            background: #f0f8ff;
            overflow: hidden;
            min-height: 320px;
            border: 2px solid #e6f3ff;
        }

        /* Rest of your existing CSS... */
        .map-container svg {
            width: 100%;
            height: 100%;
            position: absolute;
            top: 0;
            left: 0;
        }

        .map-overlay {
            position: absolute;
            top: 0;
            left: 0;
            right: 0;
            bottom: 0;
        }

        .map-point {
            position: absolute;
            width: 20px;
            height: 20px;
            border-radius: 50%;
            transform: translate(-50%, -50%);
            cursor: pointer;
            transition: all 0.3s ease;
            border: 3px solid white;
            box-shadow: 0 2px 4px rgba(0,0,0,0.3);
        }

        .map-point:hover {
            transform: translate(-50%, -50%) scale(1.2);
            z-index: 10;
        }

        .map-point.patient {
            background: #ff4444;
            width: 24px;
            height: 24px;
            z-index: 10;
        }

        .map-point.trial {
            background: #28a745;
        }

        .map-tooltip {
            position: absolute;
            background: white;
            padding: 8px 12px;
            border-radius: 6px;
            box-shadow: 0 2px 8px rgba(0,0,0,0.2);
            font-size: 0.8em;
            display: none;
            z-index: 20;
            white-space: nowrap;
        }

        .map-legend {
            position: absolute;
            bottom: 15px;
            left: 15px;
            background: white;
            padding: 10px 14px; /* CHANGED: horizontal padding increased */
            border-radius: 6px;
            box-shadow: 0 2px 4px rgba(0,0,0,0.2);
            font-size: 0.8em;
            z-index: 15;
            display: flex; /* ADDED: horizontal layout */
            flex-direction: column; /* ADDED: stack rows vertically */
            gap: 6px; /* ADDED: gap between rows */
            width: fit-content; /* ADDED: only as wide as content needs */
            min-width: 110px;
            max-width: 180px; /* ADDED: maximum width limit */
        }

        .legend-item {
            display: flex;
            align-items: center;
            gap: 8px;
            margin-bottom: 0; /* REMOVED: margin since we use gap now */
            white-space: nowrap; /* ADDED: prevent text wrapping */
            font-size: 1em;
        }

        .legend-item:last-child {
            margin-bottom: 0;
        }

        .legend-dot {
            width: 12px;
            height: 12px;
            border-radius: 50%;
            border: 2px solid white;
            box-shadow: 0 1px 3px rgba(0,0,0,0.3);
            flex-shrink: 0; /* ADDED: prevent dot from shrinking */
        }

        /* Trial sections */
        .section-grid {
            margin-bottom: 30px;
            background: #fff;
            border-radius: 12px;
            box-shadow: 0 4px 6px rgba(0,0,0,0.1);
            margin-top: 20px; /* ADDED: Extra top margin */
            clear: both; /* ADDED: Clear any floats */
        }

        .section-header-grid {
            padding: 25px 20px; 
            border-bottom: 2px solid #667eea;
            display: flex;
            justify-content: space-between;
            align-items: center;
            position: relative; 
            z-index: 1; 
        }

        .trial-count-grid {
            color: white;
            padding: 8px 16px;
            border-radius: 20px;
            font-size: 0.9em;
            font-weight: bold;
        }

        .trials-grid-layout {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(400px, 1fr));
            gap: 20px;
            padding: 20px;
        }

        .trial-card-grid {
            border: 1px solid #e9ecef;
            border-radius: 12px;
            padding: 20px;
            background: #fff;
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0,0,0,0.05);
        }

        .trial-card-grid:hover {
            border-color: #667eea;
            box-shadow: 0 4px 12px rgba(102,126,234,0.15);
            transform: translateY(-2px);
        }

        .trial-header-grid {
            display: flex;
            justify-content: space-between;
            align-items: flex-start;
            margin-bottom: 12px;
        }

        .trial-title-grid {
            font-size: 1em;
            font-weight: bold;
            color: #2c3e50;
            line-height: 1.3;
            flex: 1;
            margin-right: 12px;
        }

        .score-badge-grid {
            padding: 6px 12px;
            border-radius: 15px;
            font-size: 0.85em;
            font-weight: bold;
            white-space: nowrap;
            min-width: 50px;
            text-align: center;
        }

        .score-green-grid {
            background: #28a745;
            color: white;
            box-shadow: 0 2px 4px rgba(40, 167, 69, 0.3);
        }

        .score-yellow-grid {
            background: #ffc107;
            color: #000;
            box-shadow: 0 2px 4px rgba(255, 193, 7, 0.3);
        }

        .score-orange-grid {
            background: #fd7e14;
            color: white;
            box-shadow: 0 2px 4px rgba(253, 126, 20, 0.3);
        }

        .score-red-grid {
            background: #dc3545;
            color: white;
            box-shadow: 0 2px 4px rgba(220, 53, 69, 0.3);
        }

        .trial-meta-grid {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-bottom: 12px;
            padding-bottom: 8px;
            border-bottom: 1px solid #e9ecef;
        }

        .nct-id-grid {
            background: #007bff;
            color: white;
            padding: 4px 10px;
            border-radius: 12px;
            font-size: 0.8em;
            font-weight: 600;
        }

        .study-type-grid {
            color: #6c757d;
            font-size: 0.8em;
            font-style: italic;
        }

        .match-indicators-grid {
            display: flex;
            gap: 6px;
            margin-bottom: 10px;
            flex-wrap: wrap;
        }

        .match-tag-grid {
            background: #e3f2fd;
            color: #1565c0;
            padding: 3px 8px;
            border-radius: 10px;
            font-size: 0.7em;
            font-weight: 500;
        }

        .match-tag-grid.gene {
            background: #e8f5e8;
            color: #2e7d32;
        }

        .match-tag-grid.ecog {
            background: #fff3e0;
            color: #f57c00;
        }

        .trial-summary-grid {
            font-size: 0.85em;
            color: #495057;
            line-height: 1.4;
            margin-bottom: 15px;
            min-height: 60px;
        }

        /* Trial location info */
        .trial-location {
            display: flex;
            align-items: center;
            gap: 8px;
            margin-top: 12px;
            padding: 10px;
            background: #f8f9fa;
            border-radius: 8px;
            font-size: 0.85em;
        }

        .location-icon {
            color: #007bff;
            font-size: 1.2em;
        }

        .distance-badge {
            margin-left: auto;
            background: #e3f2fd;
            color: #1565c0;
            padding: 3px 10px;
            border-radius: 12px;
            font-size: 0.8em;
            font-weight: 600;
        }

        .action-buttons-grid {
            display: flex;
            gap: 8px;
            margin-top: 12px;
        }

        .btn-grid {
            padding: 8px 16px;
            border: none;
            border-radius: 20px;
            font-size: 0.8em;
            font-weight: 600;
            text-decoration: none;
            cursor: pointer;
            transition: all 0.3s ease;
            text-align: center;
        }

        .btn-primary-grid {
            background: #007bff;
            color: white;
            flex: 1;
            min-width: 100px;
        }

        .btn-primary-grid:hover {
            background: #0056b3;
            transform: translateY(-1px);
        }

        .expand-btn-grid {
            background: none;
            border: 1px solid #dee2e6;
            color: #6c757d;
            padding: 6px 12px;
            font-size: 0.75em;
            flex: 1.5;
            min-width: 120px;
        }

        .expand-btn-grid:hover {
            background-color: #e9ecef;
            border-color: #adb5bd;
        }

        .trial-details-grid {
            animation: slideDown 0.3s ease-out;
        }

        @keyframes slideDown {
            from {
                opacity: 0;
                max-height: 0;
                transform: translateY(-5px);
            }
            to {
                opacity: 1;
                max-height: 400px;
                transform: translateY(0);
            }
        }

        .footer {
            background: #2c3e50;
            color: white;
            padding: 20px;
            border-radius: 10px;
            text-align: center;
            margin-top: 30px;
        }

        @media (max-width: 1200px) {
            .visual-summary {
                grid-template-columns: 1fr;
                height: auto;
                margin-bottom: 25px; 
            }
            
            .medical-profile-card,
            .chart-container,
            .map-card {
                margin-bottom: 20px;
                min-height: auto; 
            }
        }

        @media (max-width: 768px) {
            .section-header-grid {
                padding: 20px 15px; /* ADDED: Reduced padding on mobile */
            }
            
            .visual-summary {
                margin-bottom: 20px; /* ADDED: Reduced margin on mobile */
            }
            
            .spotlight-container {
                flex-direction: column;
            }
        
            .spotlight-feature {
                padding: 15px 20px; /* CHANGED: from 15px 25px to 15px 20px */
            }
        
            .spotlight-number {
                font-size: 2.5em; /* ADDED: Smaller font on mobile */
            }
        
            .stats-boxes-row {
                grid-template-columns: 1fr;
                gap: 8px;
            }
        
            .other-matches-chart {
                min-height: 180px;
            }
        
            .trials-grid-layout {
                grid-template-columns: 1fr;
            }
        
            .map-container {
                min-height: 300px;
            }
        }

        /* Enhanced Map Controls */
        .map-controls {
            position: absolute;
            top: 15px;
            right: 15px;
            z-index: 1000;
            display: flex;
            flex-direction: column;
            gap: 8px;
        }

        .map-control-btn {
            background: rgba(255, 255, 255, 0.95);
            border: none;
            padding: 10px 14px;
            border-radius: 6px;
            box-shadow: 0 2px 8px rgba(0,0,0,0.15);
            cursor: pointer;
            font-size: 0.85em;
            font-weight: 600;
            transition: all 0.3s ease;
            backdrop-filter: blur(10px);
            border: 1px solid rgba(255, 255, 255, 0.2);
            white-space: nowrap;
        }

        .map-control-btn:hover {
            background: #f8f9fa;
            transform: translateY(-1px);
            box-shadow: 0 4px 12px rgba(0,0,0,0.2);
        }

        /* Enhanced Legend Styling */
        .leaflet-bottom.leaflet-left .leaflet-control {
            margin-bottom: 20px;
            margin-left: 20px;
        }

        .enhanced-map-legend {
            background: rgba(255, 255, 255, 0.95) !important;
            padding: 15px !important;
            border-radius: 10px !important;
            box-shadow: 0 4px 15px rgba(0,0,0,0.15) !important;
            backdrop-filter: blur(10px);
            border: 1px solid rgba(255, 255, 255, 0.2) !important;
            font-family: 'Segoe UI', sans-serif !important;
        }

        .enhanced-map-legend h4 {
            margin: 0 0 12px 0;
            color: #2c3e50;
            font-size: 1em;
            font-weight: 600;
        }

        .enhanced-map-legend .legend-item {
            display: flex;
            align-items: center;
            margin-bottom: 8px;
            gap: 10px;
            font-size: 0.9em;
        }

        .enhanced-map-legend .legend-dot {
            width: 14px;
            height: 14px;
            border-radius: 50%;
            border: 2px solid white;
            box-shadow: 0 2px 4px rgba(0,0,0,0.2);
            flex-shrink: 0;
        }

        .enhanced-map-legend .legend-line {
            width: 25px;
            height: 3px;
            background: #3498db;
            border-radius: 2px;
            opacity: 0.8;
            flex-shrink: 0;
        }

        /* Animated Flight Path Styles */
        .flight-path-animated {
          stroke: #ff0000 !important;
          stroke-width: 6 !important;
          stroke-dasharray: 20 10 !important;   /* ËôöÁ∫ø */
          stroke-opacity: 1 !important;
          vector-effect: non-scaling-stroke;    /* Áº©Êîæ‰∏çÂèòÁ≤óÁªÜ */
          animation: flight-dash 3s linear infinite;
        }
        
        @keyframes flight-dash {
          0%   { stroke-dashoffset: 0; }
          100% { stroke-dashoffset: -40; }
        }

        /* Enhanced Marker Styles */
        .patient-marker-enhanced {
            animation: pulse-enhanced 2s infinite;
        }

        @keyframes pulse-enhanced {
            0% { 
                box-shadow: 0 0 0 0 rgba(231, 76, 60, 0.7);
                transform: scale(1);
            }
            50% { 
                box-shadow: 0 0 0 10px rgba(231, 76, 60, 0);
                transform: scale(1.05);
            }
            100% { 
                box-shadow: 0 0 0 0 rgba(231, 76, 60, 0);
                transform: scale(1);
            }
        }

        .trial-marker-enhanced {
            transition: all 0.3s ease;
        }

        .trial-marker-enhanced:hover {
            transform: scale(1.2);
            filter: drop-shadow(0 4px 8px rgba(39, 174, 96, 0.5));
        }
        @keyframes flight-dash {
            0% { stroke-dashoffset: 0; }
            100% { stroke-dashoffset: -40; }
        }
        
        @keyframes pulse-enhanced {
            0% { 
                box-shadow: 0 4px 12px rgba(231, 76, 60, 0.5);
                transform: scale(1);
            }
            50% { 
                box-shadow: 0 4px 12px rgba(231, 76, 60, 0.5), 0 0 0 10px rgba(231, 76, 60, 0.2);
                transform: scale(1.05);
            }
            100% { 
                box-shadow: 0 4px 12px rgba(231, 76, 60, 0.5);
                transform: scale(1);
            }
        }
        /* force flight paths visible in Safari / any browser */
        .flight-path-animated {
          stroke: #FF0000 !important;
          stroke-width: 6 !important;
          stroke-dasharray: 20 10 !important;
          stroke-opacity: 1 !important;
        }
        
        .leaflet-pane.leaflet-flightPaths-pane path.flight-path-animated {
            stroke: #FF0000 !important;
            stroke-width: 6px !important;
            stroke-dasharray: 20 10 !important;
            stroke-opacity: 1 !important;
            visibility: visible !important;
            display: inline !important;
            vector-effect: non-scaling-stroke;
            animation: flight-dash 2s linear infinite !important;
        }
    </style>
    
</head>
<body>
    <div class="container">
        <!-- Header -->
        <div class="header">
            <h1>üéØ Clinical Trial Matching Report</h1>
            <p>Compact Visual Report | Generated on June 08, 2025 at 10:31 PM EST</p>
        </div>

        <!-- Visual Summary with Charts -->
        
        <div class="visual-summary">
            <!-- Medical Profile Card -->
            <div class="medical-profile-card">
                <div class="profile-header">MY MEDICAL PROFILE</div>

                <div class="profile-section">
                    <h4>Patient Information</h4>
                    <div class="profile-item">
                        <span class="profile-label">Name:</span>
                        <span class="profile-value">John Doe</span>
                    </div>
                    <div class="profile-item">
                        <span class="profile-label">Date of Birth:</span>
                        <span class="profile-value">03/15/1965</span>
                    </div>
                    <div class="profile-item">
                        <span class="profile-label">Age:</span>
                        <span class="profile-value">60 years</span>
                    </div>
                    <div class="profile-item">
                        <span class="profile-label">Gender:</span>
                        <span class="profile-value">Male</span>
                    </div>
                </div>

                <div class="profile-section">
                    <h4>Diagnosis</h4>
                    <div class="profile-item">
                        <span class="profile-label">Cancer Type:</span>
                        <span class="profile-value">Colorectal</span>
                    </div>
                    <div class="profile-item">
                        <span class="profile-label">Gene Mutation:</span>
                        <span class="profile-value">KRAS</span>
                    </div>
                    <div class="profile-item">
                        <span class="profile-label">Disease Status:</span>
                        <span class="profile-value">Metastatic</span>
                    </div>
                </div>

                <div class="profile-section">
                    <h4>Location</h4>
                    <div class="profile-item">
                        <span class="profile-label">Current:</span>
                        <span class="profile-value">New York, NY</span>
                    </div>
                    <div class="profile-item">
                        <span class="profile-label">Preferred Country:</span>
                        <span class="profile-value">United States</span>
                    </div>
                </div>
            </div>

            <!-- Match Results Section with Stats -->
            <div class="chart-container spotlight-section">
                <h3>üéØ Match Results</h3>
                <div class="spotlight-container">
                    <div class="spotlight-feature">
                        <div class="spotlight-number" id="spotlightNumber">0</div>
                        <div class="spotlight-label">High-Priority</div>
                        <div class="spotlight-subtitle">Matches Found!</div>
                    </div>

                    <!-- Stats Boxes Row -->
                    <div class="stats-boxes-row">
                        <div class="stat-box">
                            <div class="stat-number">1826</div>
                            <div class="stat-label">Trials</div>
                            <div class="stat-subtitle">Searched</div>
                        </div>
                        <div class="stat-box">
                            <div class="stat-number">1826</div>
                            <div class="stat-label">Qualified</div>
                            <div class="stat-subtitle">Matches</div>
                        </div>
                        <div class="stat-box">
                            <div class="stat-number">86%</div>
                            <div class="stat-label">Best</div>
                            <div class="stat-subtitle">Match</div>
                        </div>
                    </div>

                    <div class="other-matches-chart">
                        <canvas id="otherMatchesChart" width="300" height="200"></canvas>
                    </div>
                </div>
            </div>

            <!-- Enhanced Interactive Trial Locations Map -->
            <div class="map-card">
                <div class="map-header">
                    <span>‚úàÔ∏è Trial Locations & Flight Routes</span>
                    <span style="font-size: 0.9em; color: #6c757d;" id="mapLocationCount">11 high-priority locations</span>
                </div>
                
                <!-- Enhanced map container with better styling -->
                <div class="map-container" id="trialMapContainer" style="position: relative;">
                    <div id="leafletMap" style="
                        width: 100%; 
                        height: 100%; 
                        min-height: 350px; 
                        border-radius: 8px;
                        box-shadow: inset 0 2px 4px rgba(0,0,0,0.1);
                    "></div>
                </div>
            </div>
        </div>
    

        <!-- Trial Sections -->
        
        <div class="section-grid">
            <div class="section-header-grid">
                <div class="section-title-area">
                    <h2 style="color: #2c3e50; font-size: 1.4em; margin-bottom: 5px;">üåü High-Priority Matches (75%+)</h2>
                </div>
                <div class="trial-count-grid" style="background: #28a745;">
                    12 trials
                </div>
            </div>
            <div class="trials-grid-layout">
                
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">An Open-label, Multicenter, Single-arm Phase II Clinical Study Evaluating the Ef...</div>
                <div class="score-badge-grid score-green-grid">86%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06959589</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid gene">Gene Match</span><span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                This is an open-label, multicenter, single-arm Phase II clinical study, divided into subgroups A and B:

Cohort A - To e...
            </div>

            
            <div class="trial-location">
                <span class="location-icon">üìç</span>
                <span><strong>The Second Affiliated Hospital, School of Medicine, Zhejiang University</strong> - Hangzhou, Zhejiang</span>
                <span class="distance-badge">Calculating...</span>
            </div>
        

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06959589" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06959589" onclick="toggleDetails('06959589')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06959589" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Cancer Match: Colorectal trial specifically designed for your diagnosis</div><div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Genetic Match: KRAS targeted therapy trial</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Balstilimab and B...</div>
                <div class="score-badge-grid score-green-grid">86%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06411691</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid gene">Gene Match</span><span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                Phase 1b study evaluating the efficacy and immune response to a synthetic long peptide mutant KRAS vaccine (SPL mKRASvax...
            </div>

            
            <div class="trial-location">
                <span class="location-icon">üìç</span>
                <span><strong>Sidney Kimmel Comprehensive Cancer Center</strong> - Baltimore, Maryland</span>
                <span class="distance-badge">Calculating...</span>
            </div>
        

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06411691" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06411691" onclick="toggleDetails('06411691')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06411691" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Cancer Match: Colorectal trial specifically designed for your diagnosis</div><div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Genetic Match: KRAS targeted therapy trial</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">A Randomized, Open-label Phase 3 Study of Amivantamab + FOLFIRI Versus Cetuximab...</div>
                <div class="score-badge-grid score-green-grid">86%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06750094</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid gene">Gene Match</span><span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                The purpose of this study is to compare how long the participants are disease-free (progression-free survival) and and t...
            </div>

            
            <div class="trial-location">
                <span class="location-icon">üìç</span>
                <span><strong>Ironwood Cancer and Research Center</strong> - Chandler, Arizona</span>
                <span class="distance-badge">Calculating...</span>
            </div>
        

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06750094" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06750094" onclick="toggleDetails('06750094')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06750094" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Cancer Match: Colorectal trial specifically designed for your diagnosis</div><div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Genetic Match: KRAS targeted therapy trial</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">A Randomized, Open-label Phase 3 Study of Amivantamab and mFOLFOX6 or FOLFIRI Ve...</div>
                <div class="score-badge-grid score-green-grid">86%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06662786</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid gene">Gene Match</span><span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                The purpose of this study is to compare how long the participants are disease-free (progression-free survival) when trea...
            </div>

            
            <div class="trial-location">
                <span class="location-icon">üìç</span>
                <span><strong>St. Bernard's Medical Center</strong> - Jonesboro, Arkansas</span>
                <span class="distance-badge">Calculating...</span>
            </div>
        

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06662786" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06662786" onclick="toggleDetails('06662786')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06662786" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Cancer Match: Colorectal trial specifically designed for your diagnosis</div><div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Genetic Match: KRAS targeted therapy trial</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">A Phase Ib, Open Lable, Clinical Trial of JAB-21822 Combined With Second Line Ch...</div>
                <div class="score-badge-grid score-green-grid">86%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06838338</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid gene">Gene Match</span><span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                KRAS is a common genetic mutation in tumors, and CRC is one of the tumors with a high KRAS mutation rate. The anti-tumor...
            </div>

            
            <div class="trial-location">
                <span class="location-icon">üìç</span>
                <span><strong>Beijing Cancer Hospital</strong> - Beijing, Beijing</span>
                <span class="distance-badge">Calculating...</span>
            </div>
        

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06838338" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06838338" onclick="toggleDetails('06838338')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06838338" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Cancer Match: Colorectal trial specifically designed for your diagnosis</div><div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Genetic Match: KRAS targeted therapy trial</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">Phase 3 Multicenter, Randomized, Open-label, Active-controlled Study of Sotorasi...</div>
                <div class="score-badge-grid score-green-grid">86%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06252649</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid gene">Gene Match</span><span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                The aim of this study is to compare progression free survival (PFS) in treatment-na√Øve Participants with KRAS p.G12C mut...
            </div>

            
            <div class="trial-location">
                <span class="location-icon">üìç</span>
                <span><strong>Ironwood Cancer and Research Centers Scottsdale</strong> - Chandler, Arizona</span>
                <span class="distance-badge">Calculating...</span>
            </div>
        

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06252649" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06252649" onclick="toggleDetails('06252649')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06252649" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Cancer Match: Colorectal trial specifically designed for your diagnosis</div><div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Genetic Match: KRAS targeted therapy trial</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">A Phase Ib Study of Botensilimab Plus Balstilimab and Fasting-Mimicking Diet (FM...</div>
                <div class="score-badge-grid score-green-grid">86%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06336902</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid gene">Gene Match</span><span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                This phase Ib trial tests the safety, side effects, and effectiveness of botensilimab, and balstilimab in combination wi...
            </div>

            
            <div class="trial-location">
                <span class="location-icon">üìç</span>
                <span><strong>Los Angeles General Medical Center</strong> - Los Angeles, California</span>
                <span class="distance-badge">Calculating...</span>
            </div>
        

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06336902" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06336902" onclick="toggleDetails('06336902')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06336902" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Cancer Match: Colorectal trial specifically designed for your diagnosis</div><div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Genetic Match: KRAS targeted therapy trial</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">Efficacy and Safety of Triweekly Cetuximab in Combination With Capecitabine as F...</div>
                <div class="score-badge-grid score-green-grid">86%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT05775900</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid gene">Gene Match</span><span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                To explore the safety, efficacy and pharmacokinetic (PK) characteristics of triweekly cetuximab in combination with cape...
            </div>

            
            <div class="trial-location">
                <span class="location-icon">üìç</span>
                <span><strong>The Sixth Affiliated Hospital of Sun Yat-sen University</strong> - Guangzhou, Guangdong</span>
                <span class="distance-badge">Calculating...</span>
            </div>
        

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT05775900" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-05775900" onclick="toggleDetails('05775900')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-05775900" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Cancer Match: Colorectal trial specifically designed for your diagnosis</div><div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Genetic Match: KRAS targeted therapy trial</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Sa...</div>
                <div class="score-badge-grid score-green-grid">86%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06997497</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid gene">Gene Match</span><span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                Researchers are looking for other ways to treat locally advanced or metastatic colorectal cancer (mCRC) that is unresect...
            </div>

            

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06997497" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06997497" onclick="toggleDetails('06997497')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06997497" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Cancer Match: Colorectal trial specifically designed for your diagnosis</div><div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Genetic Match: KRAS targeted therapy trial</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipi...</div>
                <div class="score-badge-grid score-green-grid">86%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT04117087</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid gene">Gene Match</span><span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                Phase 1 study for patients with resected PDAC after neoadjuvant and/ or adjuvant chemotherapy and/or radiation, as well ...
            </div>

            
            <div class="trial-location">
                <span class="location-icon">üìç</span>
                <span><strong>Sidney Kimmel Comprehensive Cancer Center</strong> - Baltimore, Maryland</span>
                <span class="distance-badge">Calculating...</span>
            </div>
        

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT04117087" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-04117087" onclick="toggleDetails('04117087')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-04117087" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Cancer Match: Colorectal trial specifically designed for your diagnosis</div><div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Genetic Match: KRAS targeted therapy trial</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">A Clinical Study of IX001 TCR-T In the Treatment of Advanced Pancreatic Cancer a...</div>
                <div class="score-badge-grid score-green-grid">86%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06487377</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid gene">Gene Match</span><span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                This is a single-arm, single-center, open-label clinical study aimed at evaluating the safety and efficacy of IX001 TCR-...
            </div>

            
            <div class="trial-location">
                <span class="location-icon">üìç</span>
                <span><strong>Shanghai Pudong Hospital</strong> - Shanghai, Shanghai</span>
                <span class="distance-badge">Calculating...</span>
            </div>
        

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06487377" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06487377" onclick="toggleDetails('06487377')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06487377" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Cancer Match: Colorectal trial specifically designed for your diagnosis</div><div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Genetic Match: KRAS targeted therapy trial</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metas...</div>
                <div class="score-badge-grid score-green-grid">86%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06412198</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid gene">Gene Match</span><span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                To learn if the drug combination of adagrasib, cetuximab, and cemiplimab can help to control metastatic CRC with KRAS G1...
            </div>

            
            <div class="trial-location">
                <span class="location-icon">üìç</span>
                <span><strong>Massachusetts General Hospital Cancer Center</strong> - Boston, Massachusetts</span>
                <span class="distance-badge">Calculating...</span>
            </div>
        

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06412198" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06412198" onclick="toggleDetails('06412198')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06412198" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Cancer Match: Colorectal trial specifically designed for your diagnosis</div><div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Genetic Match: KRAS targeted therapy trial</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
            </div>
        </div>
    
        
        <div class="section-grid">
            <div class="section-header-grid">
                <div class="section-title-area">
                    <h2 style="color: #2c3e50; font-size: 1.4em; margin-bottom: 5px;">‚ú® Very Good Matches (60-74%)</h2>
                </div>
                <div class="trial-count-grid" style="background: #ffc107;">
                    826 trials
                </div>
            </div>
            <div class="trials-grid-layout">
                
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">A Phase 1, Open-Label, Multicenter Study of INCB161734 in Participants With Adva...</div>
                <div class="score-badge-grid score-yellow-grid">71%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06179160</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid gene">Gene Match</span><span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                This study is conducted to determine the safety and tolerability of INCB161734 as a single agent or in combination with ...
            </div>

            
            <div class="trial-location">
                <span class="location-icon">üìç</span>
                <span><strong>Mayo Clinic Hospital</strong> - Phoenix, Arizona</span>
                <span class="distance-badge">Calculating...</span>
            </div>
        

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06179160" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06179160" onclick="toggleDetails('06179160')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06179160" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Broad Eligibility: Pan-cancer trial accepts multiple cancer types</div><div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Genetic Match: KRAS targeted therapy trial</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">A Phase Ia/Ib Dose-Escalation and Dose-Expansion Study Evaluating the Safety, Ph...</div>
                <div class="score-badge-grid score-yellow-grid">71%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT04449874</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid gene">Gene Match</span><span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                This is a Phase I dose-escalation and dose-expansion study that will evaluate the safety, pharmacokinetics (PK), and pre...
            </div>

            
            <div class="trial-location">
                <span class="location-icon">üìç</span>
                <span><strong>City of Hope Comprehensive Cancer Center</strong> - Duarte, California</span>
                <span class="distance-badge">Calculating...</span>
            </div>
        

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT04449874" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-04449874" onclick="toggleDetails('04449874')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-04449874" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Broad Eligibility: Pan-cancer trial accepts multiple cancer types</div><div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Genetic Match: KRAS targeted therapy trial</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">A Phase 1, Open Label, Dose Escalation of HBI-2438 in Patients With Advanced Mal...</div>
                <div class="score-badge-grid score-yellow-grid">71%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT05485974</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid gene">Gene Match</span><span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                A Phase 1 dose escalation study in patients with advanced solid tumors harboring KRAS G12C mutation to determine the max...
            </div>

            
            <div class="trial-location">
                <span class="location-icon">üìç</span>
                <span><strong>California Cancer Associates for Research and Excellence, Inc. (cCare)</strong> - Encinitas, California</span>
                <span class="distance-badge">Calculating...</span>
            </div>
        

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT05485974" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-05485974" onclick="toggleDetails('05485974')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-05485974" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Broad Eligibility: Pan-cancer trial accepts multiple cancer types</div><div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Genetic Match: KRAS targeted therapy trial</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">A Phase Ib Clinical Trial to Evaluate the Administration of Autologous T-cells G...</div>
                <div class="score-badge-grid score-yellow-grid">71%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06253520</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid gene">Gene Match</span><span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                Background:

Many cancer cells produce substances called antigens that are unique to each cancer. These antigens stimula...
            </div>

            
            <div class="trial-location">
                <span class="location-icon">üìç</span>
                <span><strong>National Institutes of Health Clinical Center</strong> - Bethesda, Maryland</span>
                <span class="distance-badge">Calculating...</span>
            </div>
        

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06253520" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06253520" onclick="toggleDetails('06253520')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06253520" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Broad Eligibility: Pan-cancer trial accepts multiple cancer types</div><div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Genetic Match: KRAS targeted therapy trial</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">A Phase 1/2 Multiple Expansion Cohort Trial of the SOS1 Inhibitor MRTX0902 in Pa...</div>
                <div class="score-badge-grid score-yellow-grid">71%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT05578092</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid gene">Gene Match</span><span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                This is a Phase 1/2, open-label, multicenter, study evaluating the safety, tolerability, PK, PD, and anti-tumor activity...
            </div>

            
            <div class="trial-location">
                <span class="location-icon">üìç</span>
                <span><strong>Local Institution - 001-120</strong> - Colorado Springs, Colorado</span>
                <span class="distance-badge">Calculating...</span>
            </div>
        

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT05578092" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-05578092" onclick="toggleDetails('05578092')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-05578092" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Broad Eligibility: Pan-cancer trial accepts multiple cancer types</div><div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Genetic Match: KRAS targeted therapy trial</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">A Phase 1/2 Study of LY3537982 in Patients With KRAS G12C-Mutant Advanced Solid ...</div>
                <div class="score-badge-grid score-yellow-grid">71%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT04956640</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid gene">Gene Match</span><span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                The purpose of this study is to find out whether the study drug, LY3537982, is safe and effective in cancer patients who...
            </div>

            
            <div class="trial-location">
                <span class="location-icon">üìç</span>
                <span><strong>University of Alabama at Birmingham</strong> - Birmingham, Alabama</span>
                <span class="distance-badge">Calculating...</span>
            </div>
        

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT04956640" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-04956640" onclick="toggleDetails('04956640')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-04956640" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Broad Eligibility: Pan-cancer trial accepts multiple cancer types</div><div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Genetic Match: KRAS targeted therapy trial</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">A Phase 1 Open-Label Study of PF-07934040 as a Single Agent and in Combination W...</div>
                <div class="score-badge-grid score-yellow-grid">71%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06447662</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid gene">Gene Match</span><span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                The purpose of this study is to learn about the safety and effects of the study medicine alone or when given together wi...
            </div>

            
            <div class="trial-location">
                <span class="location-icon">üìç</span>
                <span><strong>Highlands Oncology Group, PA</strong> - Fayetteville, Arkansas</span>
                <span class="distance-badge">Calculating...</span>
            </div>
        

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06447662" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06447662" onclick="toggleDetails('06447662')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06447662" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Broad Eligibility: Pan-cancer trial accepts multiple cancer types</div><div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Genetic Match: KRAS targeted therapy trial</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">A Phase 1, Open-Label, Multicenter Study of INCB186748 in Participants With Adva...</div>
                <div class="score-badge-grid score-yellow-grid">71%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06818812</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid gene">Gene Match</span><span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                The purpose of this study is to evaluate INCB186748 in Participants With Advanced or Metastatic Solid Tumors With KRAS G...
            </div>

            
            <div class="trial-location">
                <span class="location-icon">üìç</span>
                <span><strong>UCLA Healthcare Hematology-Oncology</strong> - Santa Monica, California</span>
                <span class="distance-badge">Calculating...</span>
            </div>
        

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06818812" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06818812" onclick="toggleDetails('06818812')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06818812" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Broad Eligibility: Pan-cancer trial accepts multiple cancer types</div><div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Genetic Match: KRAS targeted therapy trial</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">Phase 1/2 Study of TSN1611 in Subjects With Advanced Solid Tumors Harboring KRAS...</div>
                <div class="score-badge-grid score-yellow-grid">71%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06385925</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid gene">Gene Match</span><span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                No summary available.
            </div>

            

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06385925" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06385925" onclick="toggleDetails('06385925')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06385925" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Broad Eligibility: Pan-cancer trial accepts multiple cancer types</div><div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Genetic Match: KRAS targeted therapy trial</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">A Phase 1/1b Multiple Cohort Trial of ALTA3263 in Patients With Advanced Solid T...</div>
                <div class="score-badge-grid score-yellow-grid">71%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06835569</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid gene">Gene Match</span><span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                No summary available.
            </div>

            

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06835569" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06835569" onclick="toggleDetails('06835569')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06835569" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Broad Eligibility: Pan-cancer trial accepts multiple cancer types</div><div style="margin-bottom: 6px; padding: 4px; background: #cce5ff; color: #004085; border-radius: 4px; font-size: 0.8em;">üéØ Perfect Genetic Match: KRAS targeted therapy trial</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
            </div>
        </div>
    
        
        <div class="section-grid">
            <div class="section-header-grid">
                <div class="section-title-area">
                    <h2 style="color: #2c3e50; font-size: 1.4em; margin-bottom: 5px;">üí° Good Potential Matches (45-59%)</h2>
                </div>
                <div class="trial-count-grid" style="background: #fd7e14;">
                    980 trials
                </div>
            </div>
            <div class="trials-grid-layout">
                
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">A Platform Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid T...</div>
                <div class="score-badge-grid score-orange-grid">54%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06445062</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                No summary available.
            </div>

            

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06445062" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06445062" onclick="toggleDetails('06445062')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06445062" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Broad Eligibility: Pan-cancer trial accepts multiple cancer types</div><div style="margin-bottom: 6px; padding: 4px; background: #fff3cd; color: #856404; border-radius: 4px; font-size: 0.8em;">‚ö†Ô∏è Non-targeted trial - KRAS status may not be primary selection criteria</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">Phase 1, First-in-Human, Multicenter, Open-Label Study to Evaluate the Safety, T...</div>
                <div class="score-badge-grid score-orange-grid">54%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06026410</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                No summary available.
            </div>

            

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06026410" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06026410" onclick="toggleDetails('06026410')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06026410" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Broad Eligibility: Pan-cancer trial accepts multiple cancer types</div><div style="margin-bottom: 6px; padding: 4px; background: #fff3cd; color: #856404; border-radius: 4px; font-size: 0.8em;">‚ö†Ô∏è Non-targeted trial - KRAS status may not be primary selection criteria</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">A First-in-Human (FiH) Study of IK-595, an Oral Dual MEK/RAF Inhibitor, in Patie...</div>
                <div class="score-badge-grid score-orange-grid">54%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06270082</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                No summary available.
            </div>

            

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06270082" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06270082" onclick="toggleDetails('06270082')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06270082" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Broad Eligibility: Pan-cancer trial accepts multiple cancer types</div><div style="margin-bottom: 6px; padding: 4px; background: #fff3cd; color: #856404; border-radius: 4px; font-size: 0.8em;">‚ö†Ô∏è Non-targeted trial - KRAS status may not be primary selection criteria</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">A Multi-center, Open-label, Phase I/II Clinical Study to Evaluate the Safety, To...</div>
                <div class="score-badge-grid score-orange-grid">54%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06895031</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                No summary available.
            </div>

            

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06895031" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06895031" onclick="toggleDetails('06895031')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06895031" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Broad Eligibility: Pan-cancer trial accepts multiple cancer types</div><div style="margin-bottom: 6px; padding: 4px; background: #fff3cd; color: #856404; border-radius: 4px; font-size: 0.8em;">‚ö†Ô∏è Non-targeted trial - KRAS status may not be primary selection criteria</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] Dose Escalation Study for the Trea...</div>
                <div class="score-badge-grid score-orange-grid">54%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06048367</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                No summary available.
            </div>

            

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06048367" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06048367" onclick="toggleDetails('06048367')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06048367" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Broad Eligibility: Pan-cancer trial accepts multiple cancer types</div><div style="margin-bottom: 6px; padding: 4px; background: #fff3cd; color: #856404; border-radius: 4px; font-size: 0.8em;">‚ö†Ô∏è Non-targeted trial - KRAS status may not be primary selection criteria</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">A PHASE 1 OPEN-LABEL STUDY OF PF-07985045 AS A SINGLE-AGENT AND IN COMBINATION W...</div>
                <div class="score-badge-grid score-orange-grid">54%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06704724</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                No summary available.
            </div>

            

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06704724" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06704724" onclick="toggleDetails('06704724')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06704724" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Broad Eligibility: Pan-cancer trial accepts multiple cancer types</div><div style="margin-bottom: 6px; padding: 4px; background: #fff3cd; color: #856404; border-radius: 4px; font-size: 0.8em;">‚ö†Ô∏è Non-targeted trial - KRAS status may not be primary selection criteria</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">A Phase Ib Study Evaluating the Safety, Tolerability , PharmacokineticsÔºåActivity...</div>
                <div class="score-badge-grid score-orange-grid">54%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06963502</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                No summary available.
            </div>

            

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06963502" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06963502" onclick="toggleDetails('06963502')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06963502" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Broad Eligibility: Pan-cancer trial accepts multiple cancer types</div><div style="margin-bottom: 6px; padding: 4px; background: #fff3cd; color: #856404; border-radius: 4px; font-size: 0.8em;">‚ö†Ô∏è Non-targeted trial - KRAS status may not be primary selection criteria</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">An Open-label Phase 1/2 Dose Finding, Safety and Efficacy Study of Oral NEO212 i...</div>
                <div class="score-badge-grid score-orange-grid">54%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06047379</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                No summary available.
            </div>

            

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06047379" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06047379" onclick="toggleDetails('06047379')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06047379" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Broad Eligibility: Pan-cancer trial accepts multiple cancer types</div><div style="margin-bottom: 6px; padding: 4px; background: #fff3cd; color: #856404; border-radius: 4px; font-size: 0.8em;">‚ö†Ô∏è Non-targeted trial - KRAS status may not be primary selection criteria</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in ...</div>
                <div class="score-badge-grid score-orange-grid">54%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06105021</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                No summary available.
            </div>

            

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06105021" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06105021" onclick="toggleDetails('06105021')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06105021" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Broad Eligibility: Pan-cancer trial accepts multiple cancer types</div><div style="margin-bottom: 6px; padding: 4px; background: #fff3cd; color: #856404; border-radius: 4px; font-size: 0.8em;">‚ö†Ô∏è Non-targeted trial - KRAS status may not be primary selection criteria</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">A Phase 1a/1b Study of the PI3KŒ±:RAS Breaker BBO-10203 in Subjects With Advanced...</div>
                <div class="score-badge-grid score-orange-grid">54%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06625775</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                No summary available.
            </div>

            

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06625775" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06625775" onclick="toggleDetails('06625775')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06625775" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Broad Eligibility: Pan-cancer trial accepts multiple cancer types</div><div style="margin-bottom: 6px; padding: 4px; background: #fff3cd; color: #856404; border-radius: 4px; font-size: 0.8em;">‚ö†Ô∏è Non-targeted trial - KRAS status may not be primary selection criteria</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
            </div>
        </div>
    
        
        <div class="section-grid">
            <div class="section-header-grid">
                <div class="section-title-area">
                    <h2 style="color: #2c3e50; font-size: 1.4em; margin-bottom: 5px;">üîç Needs Review Matches (<45%)</h2>
                </div>
                <div class="trial-count-grid" style="background: #dc3545;">
                    8 trials
                </div>
            </div>
            <div class="trials-grid-layout">
                
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">A Prospective, Multicenter Clinical Study of Preservative Effect on Postoperativ...</div>
                <div class="score-badge-grid score-red-grid">44%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT05049317</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                No summary available.
            </div>

            

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT05049317" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-05049317" onclick="toggleDetails('05049317')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-05049317" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #fff3cd; color: #856404; border-radius: 4px; font-size: 0.8em;">‚ö†Ô∏è Cancer type match unclear - requires detailed eligibility review</div><div style="margin-bottom: 6px; padding: 4px; background: #fff3cd; color: #856404; border-radius: 4px; font-size: 0.8em;">‚ö†Ô∏è Non-targeted trial - KRAS status may not be primary selection criteria</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">Prophylactic Use of Tamsulosin in the Prevention of Post-operative Urinary Reten...</div>
                <div class="score-badge-grid score-red-grid">44%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT05941806</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                No summary available.
            </div>

            

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT05941806" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-05941806" onclick="toggleDetails('05941806')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-05941806" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #fff3cd; color: #856404; border-radius: 4px; font-size: 0.8em;">‚ö†Ô∏è Cancer type match unclear - requires detailed eligibility review</div><div style="margin-bottom: 6px; padding: 4px; background: #fff3cd; color: #856404; border-radius: 4px; font-size: 0.8em;">‚ö†Ô∏è Non-targeted trial - KRAS status may not be primary selection criteria</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">A Multicenter, Randomized Controlled Trial of the Efficacy, Safety and Immunogen...</div>
                <div class="score-badge-grid score-red-grid">44%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT03947775</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                No summary available.
            </div>

            

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT03947775" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-03947775" onclick="toggleDetails('03947775')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-03947775" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #fff3cd; color: #856404; border-radius: 4px; font-size: 0.8em;">‚ö†Ô∏è Cancer type match unclear - requires detailed eligibility review</div><div style="margin-bottom: 6px; padding: 4px; background: #fff3cd; color: #856404; border-radius: 4px; font-size: 0.8em;">‚ö†Ô∏è Non-targeted trial - KRAS status may not be primary selection criteria</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">Int√©r√™t de la r√©√©ducation √©rectile pr√©coce Par Sild√©nafil apr√®s radioth√©rapie et...</div>
                <div class="score-badge-grid score-red-grid">44%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06123156</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                No summary available.
            </div>

            

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06123156" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06123156" onclick="toggleDetails('06123156')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06123156" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #fff3cd; color: #856404; border-radius: 4px; font-size: 0.8em;">‚ö†Ô∏è Cancer type match unclear - requires detailed eligibility review</div><div style="margin-bottom: 6px; padding: 4px; background: #fff3cd; color: #856404; border-radius: 4px; font-size: 0.8em;">‚ö†Ô∏è Non-targeted trial - KRAS status may not be primary selection criteria</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">The Ku Ola Project</div>
                <div class="score-badge-grid score-red-grid">44%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06964633</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                No summary available.
            </div>

            

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06964633" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06964633" onclick="toggleDetails('06964633')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06964633" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #fff3cd; color: #856404; border-radius: 4px; font-size: 0.8em;">‚ö†Ô∏è Cancer type match unclear - requires detailed eligibility review</div><div style="margin-bottom: 6px; padding: 4px; background: #fff3cd; color: #856404; border-radius: 4px; font-size: 0.8em;">‚ö†Ô∏è Non-targeted trial - KRAS status may not be primary selection criteria</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">A Multicenter, Randomized, Double-Blind, Aluminum Adjuvant-Controlled Phase III ...</div>
                <div class="score-badge-grid score-red-grid">42%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06866574</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                No summary available.
            </div>

            

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06866574" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06866574" onclick="toggleDetails('06866574')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06866574" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #fff3cd; color: #856404; border-radius: 4px; font-size: 0.8em;">‚ö†Ô∏è Cancer type match unclear - requires detailed eligibility review</div><div style="margin-bottom: 6px; padding: 4px; background: #fff3cd; color: #856404; border-radius: 4px; font-size: 0.8em;">‚ö†Ô∏è Non-targeted trial - KRAS status may not be primary selection criteria</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">SCREEN-HPV: Blood Biomarkers Based Screening for HPV-driven OPC</div>
                <div class="score-badge-grid score-red-grid">42%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06528353</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                No summary available.
            </div>

            

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06528353" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06528353" onclick="toggleDetails('06528353')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06528353" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #fff3cd; color: #856404; border-radius: 4px; font-size: 0.8em;">‚ö†Ô∏è Cancer type match unclear - requires detailed eligibility review</div><div style="margin-bottom: 6px; padding: 4px; background: #fff3cd; color: #856404; border-radius: 4px; font-size: 0.8em;">‚ö†Ô∏è Non-targeted trial - KRAS status may not be primary selection criteria</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
        <div class="trial-card-grid">
            <div class="trial-header-grid">
                <div class="trial-title-grid">The Effect of Naldemedine on Opioid-induced Bowel Dysfunction. An Investigator I...</div>
                <div class="score-badge-grid score-red-grid">42%</div>
            </div>

            <div class="trial-meta-grid">
                <div class="nct-id-grid">NCT06334198</div>
                <div class="study-type-grid">INTERVENTIONAL</div>
            </div>

            <div class="match-indicators-grid">
                <span class="match-tag-grid ecog">ECOG OK</span>
            </div>

            <div class="trial-summary-grid">
                No summary available.
            </div>

            

            <div class="action-buttons-grid">
                <a href="https://clinicaltrials.gov/ct2/show/NCT06334198" class="btn-grid btn-primary-grid" target="_blank">
                    View Details
                </a>
                <button class="btn-grid expand-btn-grid" id="btn-06334198" onclick="toggleDetails('06334198')">‚ñ∂ More Details</button>
            </div>

            
            <div class="trial-details-grid" id="details-06334198" style="display: none; margin-top: 10px; padding-top: 10px; border-top: 1px solid #dee2e6;">
                <div style="margin-bottom: 6px; padding: 4px; background: #fff3cd; color: #856404; border-radius: 4px; font-size: 0.8em;">‚ö†Ô∏è Cancer type match unclear - requires detailed eligibility review</div><div style="margin-bottom: 6px; padding: 4px; background: #fff3cd; color: #856404; border-radius: 4px; font-size: 0.8em;">‚ö†Ô∏è Non-targeted trial - KRAS status may not be primary selection criteria</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Disease stage considered in matching</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Excellent Performance Status: ECOG 1 qualifies for most trials</div><div style="margin-bottom: 6px; padding: 4px; background: #d4edda; color: #155724; border-radius: 4px; font-size: 0.8em;">‚úÖ Treatment Context: Multiple treatment lines - may limit some options, No recent surgery - good trial safety profile</div>
            </div>
        
        </div>
    
            </div>
        </div>
    

        <!-- Footer -->
        <div class="footer">
            <h3>ü§ù Clinical Trial Support</h3>
            <p><strong>Support:</strong> 1-800-TRIALS | <strong>Email:</strong> support@matchreport.com</p>
            <p style="font-size: 0.9em; opacity: 0.8; margin-top: 10px;">
                Report ID: MR-20250608223137 | Generated: June 08, 2025 at 10:31 PM EST
            </p>
        </div>
    </div>

    <script>
        // Wait for DOM to be fully loaded before initializing charts
        document.addEventListener('DOMContentLoaded', function() {
            // Convert data for JavaScript
            const matchData = {"spotlight": {"count": 12, "label": "High-Priority", "subtitle": "Matches Found!"}, "other_matches": {"labels": ["Very Good", "Good Potential", "Needs Review"], "data": [826, 980, 8], "colors": ["#ffc107", "#fd7e14", "#dc3545"], "total_label": "Match Quality Distribution (1814 total)"}, "stats_boxes": {"total_searched": {"count": 1826, "label": "Trials", "subtitle": "Searched"}, "qualified_matches": {"count": 1826, "label": "Qualified", "subtitle": "Matches"}, "best_match": {"count": "86%", "label": "Best", "subtitle": "Match"}}, "total": 1826, "total_other": 1814};
            const trialLocationsData = {"user_location": {"name": "New York, NY", "lat": 40.7589, "lng": -73.9441}, "trial_locations": [{"nct_id": "NCT06959589", "facility_name": "The Second Affiliated Hospital, School of Medicine, Zhejiang University", "city": "Hangzhou", "state": "Zhejiang", "country": "China", "display_name": "Hangzhou, Zhejiang", "score": 86, "lat": 30.29365, "lng": 120.16142}, {"nct_id": "NCT06411691", "facility_name": "Sidney Kimmel Comprehensive Cancer Center", "city": "Baltimore", "state": "Maryland", "country": "United States", "display_name": "Baltimore, Maryland", "score": 86, "lat": 39.29038, "lng": -76.61219}, {"nct_id": "NCT06750094", "facility_name": "Ironwood Cancer and Research Center", "city": "Chandler", "state": "Arizona", "country": "United States", "display_name": "Chandler, Arizona", "score": 86, "lat": 33.30616, "lng": -111.84125}, {"nct_id": "NCT06662786", "facility_name": "St. Bernard's Medical Center", "city": "Jonesboro", "state": "Arkansas", "country": "United States", "display_name": "Jonesboro, Arkansas", "score": 86, "lat": 35.8423, "lng": -90.70428}, {"nct_id": "NCT06838338", "facility_name": "Beijing Cancer Hospital", "city": "Beijing", "state": "Beijing", "country": "China", "display_name": "Beijing, Beijing", "score": 86, "lat": 39.9075, "lng": 116.39723}, {"nct_id": "NCT06252649", "facility_name": "Ironwood Cancer and Research Centers Scottsdale", "city": "Chandler", "state": "Arizona", "country": "United States", "display_name": "Chandler, Arizona", "score": 86, "lat": 33.30616, "lng": -111.84125}, {"nct_id": "NCT06336902", "facility_name": "Los Angeles General Medical Center", "city": "Los Angeles", "state": "California", "country": "United States", "display_name": "Los Angeles, California", "score": 86, "lat": 34.05223, "lng": -118.24368}, {"nct_id": "NCT05775900", "facility_name": "The Sixth Affiliated Hospital of Sun Yat-sen University", "city": "Guangzhou", "state": "Guangdong", "country": "China", "display_name": "Guangzhou, Guangdong", "score": 86, "lat": 23.11667, "lng": 113.25}, {"nct_id": "NCT04117087", "facility_name": "Sidney Kimmel Comprehensive Cancer Center", "city": "Baltimore", "state": "Maryland", "country": "United States", "display_name": "Baltimore, Maryland", "score": 86, "lat": 39.29038, "lng": -76.61219}, {"nct_id": "NCT06487377", "facility_name": "Shanghai Pudong Hospital", "city": "Shanghai", "state": "Shanghai", "country": "China", "display_name": "Shanghai, Shanghai", "score": 86, "lat": 31.22222, "lng": 121.45806}, {"nct_id": "NCT06412198", "facility_name": "Massachusetts General Hospital Cancer Center", "city": "Boston", "state": "Massachusetts", "country": "United States", "display_name": "Boston, Massachusetts", "score": 86, "lat": 42.35843, "lng": -71.05977}], "total_count": 11};

            console.log('Match data loaded:', matchData);
            console.log('Trial locations data loaded:', trialLocationsData);

            // Update spotlight number with animation
            const spotlightNumber = document.getElementById('spotlightNumber');
            if (spotlightNumber && matchData.spotlight) {
                let currentNumber = 0;
                const targetNumber = matchData.spotlight.count;
                const increment = Math.ceil(targetNumber / 20) || 1;

                const counter = setInterval(() => {
                    currentNumber += increment;
                    if (currentNumber >= targetNumber) {
                        currentNumber = targetNumber;
                        clearInterval(counter);
                    }
                    spotlightNumber.textContent = currentNumber;
                }, 50);
            }

            // Other Matches Horizontal Bar Chart
            const otherCtx = document.getElementById('otherMatchesChart');
            if (otherCtx && matchData.other_matches) {
                new Chart(otherCtx, {
                    type: 'bar',
                    data: {
                        labels: matchData.other_matches.labels,
                        datasets: [{
                            data: matchData.other_matches.data,
                            backgroundColor: matchData.other_matches.colors,
                            borderWidth: 0,
                            borderRadius: 4
                        }]
                    },
                    options: {
                        indexAxis: 'y',
                        responsive: true,
                        maintainAspectRatio: false,
                        aspectRatio: 1.5,
                        plugins: {
                            legend: { display: false },
                            title: {
                                display: true,
                                text: matchData.other_matches.total_label || 'Match Quality Distribution',
                                font: { 
                                    size: 13,
                                    weight: '600'
                                },
                                padding: { bottom: 4 } 
                            },
                            tooltip: {
                                callbacks: {
                                    label: function(context) {
                                        return context.parsed.x + ' trials';
                                    }
                                }
                            }
                        },
                        scales: {
                            x: {
                                beginAtZero: true,
                                grid: { display: false },
                                ticks: {
                                    font: { 
                                        size: 10,
                                        weight: '500'
                                    },
                                    padding: 4,
                                    color: '#666',
                                    stepSize: 200
                                },
                                border: { display: false }
                            },
                            y: {
                                grid: { display: false },
                                ticks: {
                                    font: { 
                                        size: 11,
                                        weight: 'bold'
                                    },
                                    color: '#2c3e50',
                                    padding: 8,
                                    maxRotation: 0,
                                    minRotation: 0
                                }
                            }
                        },
                        layout: {
                            padding: {
                                right: 15, 
                                left: 8,    
                                bottom: 20,
                                top: 2
                            }
                        },
                        elements: {
                            bar: { borderRadius: 3 }
                        }
                    }
                });
            }

            // Update location count
            const locationCountEl = document.getElementById('mapLocationCount');
            if (locationCountEl && trialLocationsData.total_count) {
                locationCountEl.textContent = `${trialLocationsData.total_count} high-priority locations`;
            } else if (locationCountEl) {
                locationCountEl.textContent = '11 high-priority locations';
            }

            // Initialize the interactive map
            initializeTrialMap(trialLocationsData);

            // Add spotlight animation effect
            setTimeout(() => {
                const spotlightEl = document.querySelector('.spotlight-feature');
                if (spotlightEl && matchData.spotlight && matchData.spotlight.count > 0) {
                    spotlightEl.style.transform = 'scale(1.05)';
                    setTimeout(() => {
                        spotlightEl.style.transform = 'scale(1)';
                    }, 300);
                }
            }, 1500);
        });
        
function initializeTrialMap(trialLocationsData) {
    console.log('üó∫Ô∏è Initializing Enhanced Flight Route Map...');
    console.log('Data received:', trialLocationsData);

    // Check if Leaflet is loaded
    if (typeof L === 'undefined') {
        console.error('‚ùå Leaflet library not loaded!');
        return;
    }

    const mapContainer = document.getElementById('leafletMap');
    if (!mapContainer) {
        console.error('‚ùå Map container element not found');
        return;
    }

    // Validate data structure
    if (!trialLocationsData) {
        console.error('‚ùå No trial locations data provided');
        return;
    }

    const userLocation = trialLocationsData.user_location;
    const trialLocations = trialLocationsData.trial_locations || [];

    console.log('üë§ User location:', userLocation);
    console.log('üè• Trial locations count:', trialLocations.length);

    try {
        // Initialize the map - SIMPLE VERSION
        window.map = L.map('leafletMap', {
            center: [30.0, 0.0],
            zoom: 2,
            maxZoom: 12,
            minZoom: 1,
            zoomControl: true
        });

        // Add tile layer
        L.tileLayer('https://{s}.tile.openstreetmap.org/{z}/{x}/{y}.png', {
            attribution: '¬© OpenStreetMap contributors',
            maxZoom: 18
        }).addTo(window.map);

        // Store references
        let flightPaths = [];
        let trialMarkers = [];
        let userMarker = null;

        // Add User Location Marker
        if (userLocation && userLocation.lat && userLocation.lng) {
            console.log('‚úÖ Adding user marker at:', userLocation.lat, userLocation.lng);

            const patientIcon = L.divIcon({
                html: `<div style="
                    background:#e74c3c;
                    width:20px;
                    height:20px;
                    border-radius:50%;
                    border:3px solid white;
                    box-shadow:0 4px 12px rgba(231,76,60,.5);
                    position:relative;
                    z-index:1000;
                "></div>`,
                iconSize: [26, 26],
                iconAnchor: [13, 13],
                className: 'patient-marker'
            });

            userMarker = L.marker(
                [userLocation.lat, userLocation.lng],
                { icon: patientIcon, zIndexOffset: 1000 }
            ).addTo(map);

            userMarker.bindPopup(`
                <div style="text-align:center;padding:10px;font-family:'Segoe UI',sans-serif;">
                    <h4 style="margin:0 0 8px 0;color:#e74c3c;">üè† Your Location</h4>
                    <p style="margin:0;font-weight:bold;color:#2c3e50;">${userLocation.name}</p>
                </div>
            `);
        }

        // Add CSS for styling
        const animationStyle = document.createElement('style');
        animationStyle.textContent = `
            /* Force patient marker to be red */
            .patient-marker div {
                background: #e74c3c !important;
            }
            
            /* Style for paths if using SVG */
            .leaflet-overlay-pane svg path {
                stroke: #3498db !important;
                stroke-width: 2px !important;
                stroke-opacity: 0.6 !important;
                fill: none !important;
            }
        `;
        document.head.appendChild(animationStyle);

        // Process trial locations
        console.log('üè• Processing trial locations...');
        trialLocations.forEach((trial, index) => {
            // Parse coordinates
            let lat, lng;
            if (trial.lat && trial.lng) {
                lat = parseFloat(trial.lat);
                lng = parseFloat(trial.lng);
            } else if (trial.latitude && trial.longitude) {
                lat = parseFloat(trial.latitude);
                lng = parseFloat(trial.longitude);
            }

            if (!lat || !lng || isNaN(lat) || isNaN(lng)) {
                console.warn(`‚ö†Ô∏è Trial ${index + 1} missing valid coordinates`);
                return;
            }

            // Get trial info
            const facilityName = trial.facility_name || trial.name || 'Unknown Facility';
            const displayName = trial.display_name || trial.location || facilityName;
            const score = trial.score || trial.match_score || '85';

            // Create trial marker
            const trialIcon = L.divIcon({
                html: `<div style="
                    background: #27ae60;
                    width: 16px;
                    height: 16px;
                    border-radius: 50%;
                    border: 2px solid white;
                    box-shadow: 0 3px 8px rgba(39, 174, 96, 0.4);
                    position: relative;
                ">
                    <div style="
                        position: absolute;
                        top: -8px;
                        right: -8px;
                        background: white;
                        color: #27ae60;
                        border: 1px solid #27ae60;
                        border-radius: 50%;
                        width: 14px;
                        height: 14px;
                        font-size: 9px;
                        font-weight: bold;
                        display: flex;
                        align-items: center;
                        justify-content: center;
                    ">${trial.trial_count || 1}</div>
                </div>`,
                iconSize: [20, 20],
                iconAnchor: [10, 10],
                className: 'trial-marker'
            });

            const trialMarker = L.marker([lat, lng], {
                icon: trialIcon,
                zIndexOffset: 500
            }).addTo(map);

            // Calculate distance
            let distanceText = 'N/A';
            if (userLocation && userLocation.lat && userLocation.lng) {
                const distance = calculateDistance(userLocation.lat, userLocation.lng, lat, lng);
                distanceText = `${Math.round(distance)} miles`;
            }

            // Add popup
            trialMarker.bindPopup(`
                <div style="padding: 12px; min-width: 240px;">
                    <h4 style="margin: 0 0 10px 0; color: #27ae60;">üè• ${facilityName}</h4>
                    <p><strong>üìç Location:</strong> ${displayName}</p>
                    <p><strong>üéØ Match Score:</strong> ${score}%</p>
                    <p><strong>‚úàÔ∏è Distance:</strong> ${distanceText}</p>
                </div>
            `);

            trialMarkers.push(trialMarker);

            // Create flight path using CANVAS renderer
            if (userLocation && userLocation.lat && userLocation.lng) {
                console.log(`üöÄ Creating flight path from user to trial ${index + 1}`);
                
                const startPoint = [parseFloat(userLocation.lat), parseFloat(userLocation.lng)];
                const endPoint = [lat, lng];
                
                // Create curved path points
                const curvedPoints = createCurvedFlightPath(startPoint, endPoint);
                
                // Create canvas renderer for this path
                const canvasRenderer = L.canvas();
                
                // Create polyline with canvas renderer
                const flightPath = L.polyline(
                    curvedPoints,  // Use curved points instead of straight line
                    {
                        color: '#3498db',
                        weight: 2,
                        opacity: 0.6,
                        smoothFactor: 1,  // Smooth the curve
                        renderer: canvasRenderer  // This is the key!
                    }
                ).addTo(map);

                flightPaths.push(flightPath);
                console.log(`‚úÖ Added curved flight path ${index + 1} with canvas renderer`);
            }
        });

        console.log(`‚úÖ Total: ${trialMarkers.length} markers, ${flightPaths.length} flight paths`);

        // Add control buttons
        const controlContainer = L.DomUtil.create('div', 'map-controls');
        controlContainer.style.cssText = `
            position: absolute;
            top: 15px;
            right: 15px;
            z-index: 1000;
            display: flex;
            flex-direction: column;
            gap: 8px;
        `;
        mapContainer.appendChild(controlContainer);

        // Reset button
        const resetBtn = L.DomUtil.create('button', 'map-control-btn', controlContainer);
        resetBtn.innerHTML = 'üåç Reset View';
        resetBtn.style.cssText = `
            background: white;
            border: none;
            padding: 10px 14px;
            border-radius: 6px;
            box-shadow: 0 2px 8px rgba(0,0,0,0.15);
            cursor: pointer;
            font-size: 0.85em;
            font-weight: 600;
        `;
        resetBtn.onclick = function() {
            map.setView([30.0, 0.0], 2);
        };

        // Toggle paths button
        const toggleBtn = L.DomUtil.create('button', 'map-control-btn', controlContainer);
        toggleBtn.innerHTML = '‚úàÔ∏è Toggle Routes';
        let pathsVisible = true;
        toggleBtn.style.cssText = resetBtn.style.cssText;
        toggleBtn.onclick = function() {
            pathsVisible = !pathsVisible;
            flightPaths.forEach(path => {
                if (pathsVisible) {
                    path.addTo(map);
                } else {
                    path.remove();
                }
            });
            this.innerHTML = pathsVisible ? '‚úàÔ∏è Hide Routes' : '‚úàÔ∏è Show Routes';
        };

        // Add Enhanced Legend
        const legend = L.control({position: 'bottomleft'});
        legend.onAdd = function(map) {
            const div = L.DomUtil.create('div', 'enhanced-map-legend');
            div.style.cssText = `
                background: rgba(255, 255, 255, 0.9) !important;
                padding: 10px 12px !important;
                border-radius: 8px !important;
                box-shadow: 0 2px 10px rgba(0,0,0,0.12) !important;
                backdrop-filter: blur(8px);
                border: 1px solid rgba(255, 255, 255, 0.3) !important;
                font-family: 'Segoe UI', sans-serif !important;
                font-size: 0.8em !important;
                max-width: 170px !important;
            `;
            div.innerHTML = `
                <h4 style="margin: 0 0 8px 0; color: #2c3e50; font-size: 0.95em; font-weight: 600;">üó∫Ô∏è Map Legend</h4>
                <div style="display: flex; align-items: center; margin-bottom: 5px; gap: 8px;">
                    <div style="width: 12px; height: 12px; border-radius: 50%; background: #e74c3c; border: 2px solid white; box-shadow: 0 1px 3px rgba(0,0,0,0.2); flex-shrink: 0;"></div>
                    <span style="font-size: 0.9em;">Your Location</span>
                </div>
                <div style="display: flex; align-items: center; margin-bottom: 5px; gap: 8px;">
                    <div style="width: 12px; height: 12px; border-radius: 50%; background: #27ae60; border: 2px solid white; box-shadow: 0 1px 3px rgba(0,0,0,0.2); flex-shrink: 0;"></div>
                    <span style="font-size: 0.9em;">Clinical Trial Sites</span>
                </div>
                <div style="display: flex; align-items: center; gap: 8px;">
                    <div style="width: 22px; height: 2px; background: #3498db; border-radius: 1px; opacity: 0.8; flex-shrink: 0;"></div>
                    <span style="font-size: 0.9em;">Flight Routes</span>
                </div>
            `;
            return div;
        };
        legend.addTo(map);

        // Auto-fit bounds
        if (trialMarkers.length > 0 || userMarker) {
            const group = new L.featureGroup([...trialMarkers, ...(userMarker ? [userMarker] : [])]);
            map.fitBounds(group.getBounds().pad(0.1));
        }

        console.log('‚úÖ Map initialized successfully!');

    } catch (error) {
        console.error('‚ùå Error initializing map:', error);
        mapContainer.innerHTML = `
            <div style="padding: 20px; color: #dc3545; text-align: center;">
                <h4>üó∫Ô∏è Map Loading Error</h4>
                <p>Unable to load the interactive map. Please refresh the page.</p>
                <p style="font-size: 0.85em; color: #6c757d;">Error: ${error.message}</p>
            </div>
        `;
    }
}

// Helper function to create curved flight paths
function createCurvedFlightPath(start, end) {
    const points = [];
    const steps = 50;  // Number of points in the curve
    
    const lat1 = start[0];
    const lng1 = start[1];
    const lat2 = end[0];
    const lng2 = end[1];
    
    // Calculate the midpoint
    const midLat = (lat1 + lat2) / 2;
    const midLng = (lng1 + lng2) / 2;
    
    // Calculate distance to determine curve height
    const distance = Math.sqrt(
        Math.pow(lat2 - lat1, 2) + 
        Math.pow(lng2 - lng1, 2)
    );
    
    // Create a nice curve height based on distance (more curve for longer flights)
    const curveHeight = Math.min(distance * 0.2, 15);  // Max 15 degrees curve
    
    // Generate points along a quadratic bezier curve
    for (let i = 0; i <= steps; i++) {
        const t = i / steps;
        
        // Quadratic bezier curve formula
        // B(t) = (1-t)¬≤P‚ÇÄ + 2(1-t)tP‚ÇÅ + t¬≤P‚ÇÇ
        const lat = (1 - t) * (1 - t) * lat1 + 
                   2 * (1 - t) * t * (midLat + curveHeight) + 
                   t * t * lat2;
        
        const lng = (1 - t) * (1 - t) * lng1 + 
                   2 * (1 - t) * t * midLng + 
                   t * t * lng2;
        
        points.push([lat, lng]);
    }
    
    return points;
}

// Distance calculation helper
function calculateDistance(lat1, lng1, lat2, lng2) {
    const R = 3959; // Earth's radius in miles
    const dLat = (lat2 - lat1) * Math.PI / 180;
    const dLng = (lng2 - lng1) * Math.PI / 180;
    const a = Math.sin(dLat/2) * Math.sin(dLat/2) + 
              Math.cos(lat1 * Math.PI / 180) * Math.cos(lat2 * Math.PI / 180) * 
              Math.sin(dLng/2) * Math.sin(dLng/2);
    const c = 2 * Math.atan2(Math.sqrt(a), Math.sqrt(1-a));
    return R * c;
}


        // Toggle trial details function
        function toggleDetails(nctId) {
            const details = document.getElementById('details-' + nctId);
            const btn = document.getElementById('btn-' + nctId);
            if (!details || !btn) return;
            if (details.style.display === 'none' || details.style.display === '') {
                details.style.display = 'block';
                btn.innerHTML = '‚ñº Less Details';
                btn.style.backgroundColor = '#dc3545';
                btn.style.color = 'white';
            } else {
                details.style.display = 'none';
                btn.innerHTML = '‚ñ∂ More Details';
                btn.style.backgroundColor = '';
                btn.style.color = '#6c757d';
            }
        }
    </script>
</body>
</html>